Sign Out
The patient must tell the physician before receiving Zenalb 20 if any of the following conditions applies to the patient: Allergic or violent reaction to Zenalb 20 when injected. Treatment should be stopped immediately; Blood problems, especially severe anaemia, or a tendency to bleeding disorders;
Heart problems where the heart is not pumping properly (heart failure);
High blood pressure (hypertension);
Increased blood volume and associated complaints;
Severe kidney problems or a chronic liver condition;
Fluid accumulation in the lungs;
Elderly;
A young child;
Receiving regular or repeated infusions of Zenalb 20. The patient may need to have a vaccination for hepatitis A and B.
The patient will need to be monitored closely during treatment and should be checked for dehydration and salt (electrolyte) balance in the body. If the patient start to feel ill, then tell the physician immediately, because the infusion rate may have to be altered or the treatment stopped.
Water should not be added to the Zenalb 20 solution as it may cause breaking down of some of the red blood cells.
Potassium and odium are ingredients in this product.
If the patient has been told that he/she has a reduced kidney function or is on a potassium- or sodium-controlled diet, tell the physician before giving the infusion.
Effects on the Ability to Drive and Using Machines: There are no restrictions on driving or using machines after being treated with Zenalb 20.
